Optimizing Outcomes in Hypoparathyroidism: A New Era in Treatment Approaches - Episode 6
Novel Approaches in Hypoparathyroidism Management
In ‘Novel Approaches in Hypoparathyroidism Management,’ our experts delve into novel treatment options for patients who are inadequately controlled on conventional therapy and the mechanism of action of palopegteriparatide.
In ‘Novel Approaches in Hypoparathyroidism Management,’ our experts delve into novel treatment options for patients who are inadequately controlled on conventional therapy and the mechanism of action of palopegteriparatide.
Led by the moderator, the expert endocrinologists examine the following critical questions:
- How do you decide when a patient with chronic hypoparathyroidism is inadequately controlled on conventional therapy?
- How do you decide which patients with hypoparathyroidism are good candidates for treatment with parathyroid hormone or palopegteriparatide?
- What is the mechanism of action of palopegteriparatide, and how is it administered?
Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
Our next episode, ‘Evaluating the Efficacy and Safety of Palopegteriparatide in Hypoparathyroidism from the PaTHway Trial,’ further explores hypoparathyroidism, highlighting the key efficacy and safety data and study limitations from the phase 3 PaTHway trial.
